The majority of gastrointestinal stromal tumors (GISTs; 70–80%) have mutations in the KIT receptor tyrosine kinase gene resulting in constitutive ligand-independent activation of KIT intracellular signaling [1, 2]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.